{"id":960323,"date":"2026-05-08T06:08:54","date_gmt":"2026-05-08T10:08:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/"},"modified":"2026-05-08T06:08:54","modified_gmt":"2026-05-08T10:08:54","slug":"profusa-receives-favorable-nasdaq-listing-determination","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/","title":{"rendered":"Profusa Receives Favorable Nasdaq Listing Determination"},"content":{"rendered":"
\n

BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a\u00a0 digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announced that, by letter dated May 6, 2026, the Nasdaq Hearings Panel granted the Company\u2019s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company\u2019s continued listing on Nasdaq is subject to the Company\u2019s satisfaction of certain interim milestones and, ultimately, the Company\u2019s compliance with the bid price and stockholders\u2019 equity requirements for continued listing on the Capital Market tier by July 6, 2026.<\/p>\n

\n About Profusa<\/b>
\n \n <\/p>\n

Based in Berkeley, CA, Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on.<\/p>\n

\u201cLUMEE\u201d, \u201cPROFUSA\u201d and the PROFUSA logo are registered trademarks of Profusa, Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia.<\/p>\n

For more information, visit\u00a0https:\/\/profusa.com.<\/a><\/p>\n

\n Special Note Regarding Forward-Looking Statements<\/b>
\n \n <\/p>\n

Certain statements in this press release may be considered \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or future financial or operating performance of Profusa. In some cases, you can identify forward-looking statements by terminology such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cforecast,\u201d \u201cfuture,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpossible,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpropose,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201cstrive,\u201d \u201cwill,\u201d or \u201cwould\u201d or the negatives of these terms or variations of them or similar terminology. Forward\u2011looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in such statements, including but not limited to the Company\u2019s ability to obtain the required stockholder approvals, execute its compliance plan within the timeframes specified by the Panel, effect and maintain compliance with the Bid Price Rule and other applicable listing requirements, complete anticipated transactions, and other factors described in the Company\u2019s filings with the Securities and Exchange Commission (the \u201cSEC\u201d), including its Annual Report on Form 10\u2011K for the year ended December 31, 2025, and subsequent Quarterly Reports on Form 10\u2011Q and Current Reports on Form 8\u2011K.\u00a0 The Company undertakes no obligation to update any forward\u2011looking statements, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

\n Contacts<\/b>
\n \n <\/p>\n

\n Investor and Media Contacts<\/b>
\n
email:\u00a0 info@coreir.com<\/a>
phone:\u00a0 1 (212) 655-0924<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a\u00a0 digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announced that, by letter dated May 6, 2026, the Nasdaq Hearings Panel granted the Company\u2019s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company\u2019s continued listing on Nasdaq is subject to the Company\u2019s satisfaction of certain interim milestones and, ultimately, the Company\u2019s compliance with the bid price and stockholders\u2019 equity requirements for continued listing on the Capital Market tier by July 6, 2026. About Profusa Based in Berkeley, CA, Profusa is a commercial stage … <\/p>\n

Continue reading “Profusa Receives Favorable Nasdaq Listing Determination”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-960323","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nProfusa Receives Favorable Nasdaq Listing Determination - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Profusa Receives Favorable Nasdaq Listing Determination - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a\u00a0 digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announced that, by letter dated May 6, 2026, the Nasdaq Hearings Panel granted the Company\u2019s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company\u2019s continued listing on Nasdaq is subject to the Company\u2019s satisfaction of certain interim milestones and, ultimately, the Company\u2019s compliance with the bid price and stockholders\u2019 equity requirements for continued listing on the Capital Market tier by July 6, 2026. About Profusa Based in Berkeley, CA, Profusa is a commercial stage … Continue reading "Profusa Receives Favorable Nasdaq Listing Determination"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-08T10:08:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Profusa Receives Favorable Nasdaq Listing Determination\",\"datePublished\":\"2026-05-08T10:08:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/\"},\"wordCount\":479,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/\",\"name\":\"Profusa Receives Favorable Nasdaq Listing Determination - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==\",\"datePublished\":\"2026-05-08T10:08:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/profusa-receives-favorable-nasdaq-listing-determination\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Profusa Receives Favorable Nasdaq Listing Determination\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Profusa Receives Favorable Nasdaq Listing Determination - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/","og_locale":"en_US","og_type":"article","og_title":"Profusa Receives Favorable Nasdaq Listing Determination - Market Newsdesk","og_description":"BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (\u201cProfusa\u201d or the \u201cCompany\u201d) (Nasdaq: PFSA), a\u00a0 digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual\u2019s biochemistry, announced that, by letter dated May 6, 2026, the Nasdaq Hearings Panel granted the Company\u2019s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company\u2019s continued listing on Nasdaq is subject to the Company\u2019s satisfaction of certain interim milestones and, ultimately, the Company\u2019s compliance with the bid price and stockholders\u2019 equity requirements for continued listing on the Capital Market tier by July 6, 2026. About Profusa Based in Berkeley, CA, Profusa is a commercial stage … Continue reading \"Profusa Receives Favorable Nasdaq Listing Determination\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-08T10:08:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Profusa Receives Favorable Nasdaq Listing Determination","datePublished":"2026-05-08T10:08:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/"},"wordCount":479,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/","name":"Profusa Receives Favorable Nasdaq Listing Determination - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==","datePublished":"2026-05-08T10:08:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNjIwMiM3NTkxODY5IzUwMDA5ODI1NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/profusa-receives-favorable-nasdaq-listing-determination\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Profusa Receives Favorable Nasdaq Listing Determination"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/960323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=960323"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/960323\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=960323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=960323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=960323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}